Review
Open access
Aug 2026
Pathogenic group 2 innate lymphoid cells as drivers of lung fibrosis in severe asthma
Evidence for pathogenic ILC2s in severe asthma provides a mechanistic framework linking chronic type 2 inflammation to persistent airway fibrosis, and therapeutic strategies targeting alarmins, cytokines, CDKs, and steroid-resistance signaling are discussed.
Masaya Matsuda, Yuya Sannomiya, Osamu Kaminuma et al.
· Frontiers in Immunology · 0 citations